BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, May 3, 2026
Home » Authors » Katie Pfaff

Katie Pfaff

katie.pfaff@clarivate.com
Articles

ARTICLES

Diagnostics firm Karius nets $50M in series A funding round

Aug. 8, 2017
By Katie Pfaff

Reva Medical moves to direct distribution after Boston Scientific agreement expires

Aug. 7, 2017
By Katie Pfaff
Reva Medical Inc. will begin distributing its coronary and peripheral bio-resorbable scaffold devices after Boston Scientific did not renegotiate its agreement and allowed it to expire. Boston Scientific previously held exclusive rights to negotiate distribution, per the 2007 agreement.
Read More

Quanterix closes $8.5M financing for developing biomarker tests

Aug. 4, 2017
By Katie Pfaff

Laminate earns FDA IDE approval for clinical study

Aug. 3, 2017
By Katie Pfaff

Tech reflects our humanity

Aug. 2, 2017
By Katie Pfaff
When my now middle-aged dog was a puppy, I looked into taking him to basic obedience classes. At one of these sessions, a group of newbie pet owners gathered in a room tucked into the back of a pet store. Each came armed with a pocketful of treats or a clicker, hopeful to see results with their pet. As the class went on, some pets obliged their owner’s coaxing to sit or lie down, while others angled for treats. It quickly became apparent that much of the training that was necessary to make a well-behaved dog was actually on the...
Read More

Invitae to acquire Good Start Genetics and Combimatrix in combo stock and cash deal

Aug. 2, 2017
By Katie Pfaff
Genetic information firm, Invitae Corp., plans to acquire both Good Start Genetics Inc., molecular diagnostic company for preimplantation and carrier testing of inherited diseases, and Combimatrix Corp., a prenatal and pediatric diagnostic company, putting itself at the front of the family genetics space. San Francisco-based Invitae entered into definitive agreements with the two companies, which are contingent on several conditions.
Read More

Invitae Corp. acquires Good Start and Combimatrix in combo stock, cash deal

Aug. 2, 2017
By Katie Pfaff
Genetic information firm Invitae Corp. plans to acquire both Good Start Genetics Inc., a molecular diagnostic company for preimplantation and carrier testing of inherited diseases, and Combimatrix Corp., a prenatal and pediatric diagnostic company, putting itself at the front of the family genetics space.
Read More

Chocolate heart study begins, QT Vascular seeks FDA approval

Aug. 1, 2017
By Katie Pfaff

Nico-sponsored ENRICH trial doubles in size

July 31, 2017
By Katie Pfaff

Cochlear's Nucleus 7 pairs with Apple devices to directly process sound

July 28, 2017
By Katie Pfaff
View All Articles by Katie Pfaff

Popular Stories

  • AI generated image for researcher developing antisense oligonucleotides

    Bio Korea 2026 kicks off with spotlight on oligonucleotides

    BioWorld
    Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
  • University of Western Australia patents 5-HT2A/B modulators

    BioWorld Science
    University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
  • Neurons

    AA meeting of minds as PTC, Novartis push votoplam in HD

    BioWorld
    What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
  • Nerves within a melanoma tumor

    Innervation can slow, as well as speed, tumor growth, study finds

    BioWorld
    Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
  • Glucagon-like peptide-1 receptor (GLP-1R) complex

    Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control

    BioWorld
    A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing